Source - SMW
Premaitha Health has entered into an up to £2.1m secured loan facility agreement with Thermo Fisher Scientific to cover legal costs.

The loan would fund costs related to the ongoing Illumina litigation against Premaitha as notified by the company in November.

The loan was provided on a commercial basis consistent with previous loans and secured on the shares of the company's Taiwanese subsidiary, Premaitha Health said. 

At 9:22am: (LON:NIPT) Premaitha Health Plc share price was 0p at 4.5p